Sign in

NCT06330623Completed

Developing Personalised Relative Physical Activity Thresholds in COPD.

Developing Personalised, Relative Intensity Physical Activity Thresholds for Accelerometer-Derived Measures of Physical Activity in COPD (IMPACT)

Source: ClinicalTrials.gov · Last updated 19 May 2026

Brief summary (registry, in English)

The aim of this observational study is to translate the principle of individualised exercise prescription into the evaluation of daily absolute and relative intensity physical activity. The main questions this study aims to answer are: * Phase 1: What does physical activity (intensity) mean to people with COPD? * Phase 2: Are there differences between time spent in absolute and relative physical activity for people with COPD? Phase 1 Participants will take part in semi-structured interview (30-45 minutes) about living with COPD and perceptions of physical activity and how they perceive intensity. This will also include photovoice and photo-elicitation. Demographic information will be recorded and participants will also complete several respiratory symptom questionnaires. Phase 2: Participants will take part in physical activity testing before and after pulmonary rehabilitation while wearing physical activity monitors. Demographic information will be recorded and participants will also complete several respiratory symptom and physical activity questionnaires. Participants will also wear the physical activity monitors for 8 days after the pre-testing sessions and after their final pulmonary rehabilitation class. Sub-study: Participants will be asked to take images of barriers during physical activity, facilitators during physical activity, feelings during physical activity and types of physical activity they take part in for 8 days after their final pulmonary rehabilitation class. Participants will then take part in a semi-structured interview about the images their have taken while doing physical activity.

Status (registry)
Completed
Study type
Observational
Enrollment
54 (actual)
First submitted
4 Mar 2024
Start date
22 Nov 2023
Primary completion date
28 Oct 2025
Lead sponsor
University of Leicester
Diseases
COPD
NCT number
NCT06330623

What you commit to

  • Study type: Observational
  • Participants enrolled: 54
  • From 22 Nov 2023 to the primary completion date, 28 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe psychiatric disorders
  • Has had a cardiac event within last 6 weeks
  • Severe psychiatric disorders
  • Patients with a history of MRSA +ve screens (patients can be assessed and given an exercise programme but cannot attend the classes. Patients need to have 3 consecutive -ve MRSA swabs before they can attend).

Age

  • Aged less than 40 years
  • Aged less than 40 years

Other

  • Unable to provide valid informed consent.
  • Unable to understand written or spoken English.
    • Phase 2:
  • Unable to provide valid informed consent.
  • Lack of motivation to participate in PR programme.
  • Any-contra-indications absolute or relative to exercise training.
  • Unable to understand written or spoken English.

Who the study is looking for

  • Willing and able to provide informed consent for participation in the research.
  • The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria (Agustí et al., 2023).
  • Male or female, aged 40+ years
  • Able to communicate in written and spoken English.
  • Willing and able to provide informed consent for participation in the research.
  • The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria.
  • The patient is referred for PR at the UHL.
  • Male or female, aged 40+ years
  • Able to communicate in written and spoken English

Criteria the registry did not label

  • Phase 1:

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
NIHR Leicester Biomedical Research Centre - Respiratory
Coordinator of this site? Confirm its status
LeicesterUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.